Qnity Bio

Qnity Bio is a deep-tech company that has developed a quantum-electrochemical platform designed to transform molecular screening and drug discovery. Their technology utilizes custom-built chips equipped with nanogold-silicon electrodes and quantum sensing capabilities to detect molecular binding events and chemical reactions at attomolar concentrations. By providing label-free, real-time analysis, the system offers significantly higher sensitivity compared to traditional methods such as SPR and ELISA, enabling researchers to screen molecule sizes ranging from small organics to complex biologics with greater precision and scalability.

This technology addresses critical bottlenecks in pharmaceutical research, where traditional screening is often slow, expensive, and limited by low resolution. By delivering accessible, high-throughput molecular data, Qnity aims to accelerate preclinical validation and de-risk drug development decisions for innovators in the pharmaceutical and biotechnology industries. The company has engaged in strategic pilots with industry partners and is supported by specialized scientific expertise and global research initiatives, positioning its platform to expand into broader applications across proteomics, genomics, and metabolomics.